SELLAS Life Sciences Group, Inc. (SLS) Social Stream
SELLAS LIFE SCIENCES GROUP INC (SLS) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering SELLAS LIFE SCIENCES GROUP INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-08-13 | 2 | $21 | $18 | $19.5 | $0.574 | 3297.21% |
| 2021-12-03 | 1 | $21 | $16 | $18.5 | $0.574 | 3123% |
| 2022-02-09 | 2 | $21 | $15 | $17.333 | $0.574 | 2919.69% |
| 2022-04-04 | 2 | $21 | $13 | $16.666 | $0.574 | 2803.48% |
| 2022-04-07 | 3 | $21 | $13 | $16 | $0.574 | 2687.46% |
| 2022-04-08 | 3 | $16 | $12 | $13.75 | $0.574 | 2295.47% |
| 2022-05-31 | 3 | $14 | $10 | $12.25 | $0.574 | 2034.15% |
| 2022-08-12 | 3 | $14 | $6 | $11.25 | $0.574 | 1859.93% |
| 2022-08-16 | 3 | $14 | $6 | $10 | $0.574 | 1642.16% |
| 2022-11-16 | 3 | $12 | $4 | $8 | $0.574 | 1293.73% |
| 2023-02-02 | 3 | $12 | $4 | $8.25 | $0.574 | 1337.28% |
| 2023-03-20 | 3 | $12 | $3 | $8 | $0.574 | 1293.73% |
| 2023-08-16 | 3 | $9 | $3 | $6 | $0.574 | 945.3% |
| 2023-11-13 | 3 | $9 | $4 | $6.5 | $0.574 | 1032.4% |
| 2023-11-22 | 3 | $9 | $3 | $5.333 | $0.574 | 829.09% |
The Trend in the Analyst Price Target
SLS's average price target has moved down $4.67 over the prior 33 months.
SLS reports an average of 355% for its upside potential over the past 42 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-02-02 | 3 | 12 | 4 | 8.25 | 3.34 | 147.01% |
| 2023-03-20 | 3 | 12 | 3 | 8.00 | 1.28 | 525% |
| 2023-05-12 | 3 | 9 | 3 | 6.00 | 1.52 | 294.74% |
| 2023-08-14 | 3 | 9 | 3 | 6.00 | 1.52 | 294.74% |
| 2023-11-13 | 3 | 9 | 4 | 6.50 | 0.88 | 638.64% |
SLS Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 3 | 0 | 0 | 0 | 0 | 3 |
The Trend in the Broker Recommendations
SLS's average broker recommendation rating improved by 0 over the prior 39 weeks.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- SELLAS LIFE SCIENCES GROUP INC's upside potential (average analyst target price relative to current price) is higher than 1871% of all US stocks.
- SELLAS LIFE SCIENCES GROUP INC's number of analysts covering the stock is higher than 105.54% of all US stocks.
- In terms of how SELLAS LIFE SCIENCES GROUP INC fares relative to Healthcare stocks, note that its average analyst price target is higher than 407.73% of that group.
- In terms of how SELLAS LIFE SCIENCES GROUP INC fares relative to Pharmaceutical Products stocks, note that its variance in analysts' estimates is lower than -678.04% of that group.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to SELLAS LIFE SCIENCES GROUP INC are ATNM, ALT, and MNOV.
View All Top Stocks by Price Target
Make investment decisions regarding SLS using the data that counts. Try POWR Ratings for free.